Vol 7, No 2 (2018)
Research paper
Published online: 2018-04-04

open access

Page views 6250
Article views/downloads 989
Get Citation

Connect on Social Media

Connect on Social Media

Impact of physical activity on hypoglycaemia in patients with diabetes

Katarzyna Zielińska1, Dagmara Bysiak-Korus1, Agnieszka Sosna-Kondera1, Ewa Banaś1, Joanna Bosowska1, Krzysztof Strojek2
Clin Diabetol 2018;7(2):108-113.

Abstract

Aim. Assessment of the effect of the physical activity level in diabetic patients on the occurrence of hypo­glycaemia.

Material and methods. The survey was conducted in a group of 422 diabetic patients: 209 patients with type 1 diabetes mellitus (129 women, 80 men, mean age 30 ± 11 years, mean duration of diabetes 12 ± 8 years, HbA1c: 7.5 ± 1.4%) and 213 patients with type 2 diabetes mellitus (119 women, 94 men, mean age 60 ± 12 years, mean duration of diabetes 10 ± 9 years, HbA1c: 8 ± 1.5%). Patients filled in the questionnaire covering data on diabetes control and physical activity (based on the International Physical Activity Question­naire — IPAQ).

Results. Overall the number of patients with hypogly­caemia was significantly higher in patients with high physical activity (65%) when compared to low activity (43%; p < 0.01). Patients with moderate activity did not differ from remaining groups. In type 1 diabetes mellitus number of episodes was significantly lower in low activity group (4%) when compared to high activity (61%; p < 0.001) and moderate activity (17%; p < 0.001). Also significant difference was found be­tween high and moderate activity (p < 0.001). In type 2 diabetes mellitus the relation was similar. 23% patients with hypoglycaemia in high activity; 11% in modera­te activity (p < 0.005) and 5% in low activity group (p < 0.001 vs. high and moderate activity respectively).

Conclusions. The incidence of hypoglycaemia increases along with increasing physical activity. This indicates the necessity of an increased education in patients planning physical activity. (Clin Diabetol 2018; 7, 2: 108–113)  

Article available in PDF format

View PDF Download PDF file

References

  1. Colberg SR, Sigal RJ, Fernhall Bo, et al. American College of Sports Medicine, American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010; 33(12): e147–e167.
  2. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995; 273(5): 402–407.
  3. World Health Organization. The world health report 2002: reducing risk, promoting health life. Geneva, 2002.
  4. U.S. Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and F. Washington, DC, U.S., 1996.
  5. American Diabetes Association. Diabetes and exercise: the risk- -benefit profile. W: Devlin JT, Ruderman N, et al. The Health Professional’s Guide to Diabetes and Exercise. American Diabetes Association. 3-4. Alexandria, VA, 1995.
  6. Wasserman DH, Zinman B. Exercise in individuals with IDDM. Diabetes Care. 1994; 17(8): 924–937.
  7. Schneider SH, Ruderman NB. Exercise and NIDDM (Technical Review). Diabetes Care. 1990; 13(7): 785–789.
  8. Zanuso S, Jimenez A, Pugliese G, et al. Exercise for the management of type 2 diabetes: a review of the evidence. Acta Diabetol. 2010; 47(1): 15–22.
  9. American College of Sports icine. The recommended quantity and quality of exercise for demaintaining cardiorespiratory and muscular fitness in healthy adults (Position Statement). 1990.
  10. The position of Polish Diabetes Association, clinical recommendations of the management of patients with diabetes 2016] . Clinical Diabetology. 2016; 3(suplement A): suplement.
  11. Ryde´n L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2013; 34(39): 3035–3087.
  12. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 2006; 29(11): 2518–2527.
  13. Umpierre D, Ribeiro PAB, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011; 305(17): 1790–1799.
  14. Yardley JE, Kenny GP, Perkins BA, et al. Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care. 2012; 35(4): 669–675.
  15. Yardley JE, Kenny GP, Perkins BA, et al. Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes. Diabetes Care. 2013; 36: 537–542.
  16. Tonoli C, Heyman E, Roelands B, et al. Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. Sports Med. 2012; 42(12): 1059–1080.
  17. Biernat E, Stupnicki R, Gajewski AK. International Questionnaire of Physical Activity (IPAQ) - Polish version]. Wych Fiz Sport. 2007; 51: 47–54.
  18. Gajewski AK, Biernat E. Pros and cons of the International Physical Activity Questionnaire (IPAQ) use: Methodical issues and their implications. In: Buśko K, Charzewska J, Kaczanowski K. ed. Modern methods of research about activity, efficiency and physical fitness. AWF w Warszawie, Warszawie 2010: 20–37.
  19. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care. 2013; 36(5): 1384–1395.
  20. Holman RR, Paul SK, Bethel MA, et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131): 837–853.
  21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977–986.
  22. Goto A, Arah OA, Goto M, et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ. 2013; 347: f4533.
  23. Scheen AJ, Mathieu C, Giaccari A, et al. American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35(6): 1364–1379.
  24. Pontiroli AE, Miele L, Morabito A. Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis. Diabetes Obes Metab. 2012; 14(5): 433–446.
  25. Lipska KJ, Warton EM, Huang ES, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013; 36(11): 3535–3542.
  26. Thulé PM, Umpierrez G. Sulfonylureas: a new look at old therapy. Curr Diab Rep. 2014; 14(4): 473.
  27. Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab. 2008; 10 Suppl 1: 25–32.
  28. Bodmer M, Meier C, Krahenbuhl S, et al. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemi. Diabetes Care. 2008; 31(11): 2086–2091.
  29. Pilemann-Lyberg S, Thorsteinsson B, Snorgaard O, et al. Severe hypoglycaemia during treatment with sulphonylureas in patients with type 2 diabetes in the Capital Region of Denmark. Diabetes Res Clin Pract. 2015; 110(2): 202–207.
  30. Mynarski W, Psurek A, Borek Z, et al. Declared and real physical activity in patients with type 2 diabetes mellitus as assessed by the International Physical Activity Questionnaire and Caltrac accelerometer monitor: a potential tool for physical activity assessment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012; 98(1): 46–50.
  31. Davey RJ, Howe W, Paramalingam N, et al. The effect of midday moderate-intensity exercise on postexercise hypoglycemia risk in individuals with type 1 diabetes. J Clin Endocrinol Metab. 2013; 98(7): 2908–2914.
  32. Younk LM, Mikeladze M, Tate D, et al. Exercise-related hypoglycemia in diabetes mellitus. Expert Rev Endocrinol Metab. 2011; 6(1): 93–108.
  33. Cryer PE. Exercise-related hypoglycemia-associated autonomic failure in diabetes. Diabetes. 2009; 58(9): 1951–1952.